Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems

Influenza and other Respiratory Viruses

Volumn 3, Issue 2, 2009, Pages 51-58

  Brammer, Lynnette ^a,b   Budd, Alicia ^a   Cox, Nancy ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Influenza; Morbidity surveillance; Mortality surveillance; Novel influenza A viruses; Virologic surveillance

Indexed keywords

ADAMANTANE; AMANTADINE; INFLUENZA VACCINE; OSELTAMIVIR; RIMANTADINE; ZANAMIVIR;

ADVISORY COMMITTEE; DISEASE ACTIVITY; DISEASE SEVERITY; DISEASE SURVEILLANCE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; HIGH RISK PATIENT; HOSPITAL CARE; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INFECTION RISK; INFLUENZA; INFLUENZA VIRUS A; LABORATORY DIAGNOSIS; MORBIDITY; MORTALITY; OUTPATIENT CARE; PANDEMIC; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEASONAL VARIATION; VIRUS ISOLATION; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS VIRULENCE;

DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; POPULATION SURVEILLANCE; SEASONS;

EID: 62149136565     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2009.00077.x     Document Type: Review

References (20)

1. Koopmans M, Wilbrink B, Conyn M et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands [see comment]. Lancet 2004; 363: 587-593.
2. CDC. Avian Influenza Infection in Humans. 2006. Available from: http://www.cdc.gov/flu/avian/gen-info/avian-flu-humans.htm (accessed 12 January 2006).
3. Tweed SA, Skowronski DM, David ST et al. Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis 2004; 10:2196-2199.
4. Centers for Disease Control and Prevention. Isolation of avian influenza A(H5N1) viruses from humans - Hong Kong, May-December 1997. MMWR - Morb Mortal Wkly Rep 1997;46:1204-1207.
5. Uyeki TM, Chong YH, Katz JM et al. Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China 1999. Emerg Infect Dis 2002; 8:154-159.
6. Centers for Disease Control and Prevention. Update: Influenza Activity - United States and Worldwide, May 20-September 15, 2007. MMWR - Morb Mortal Wkly Rep 2007; 56:1001-1004.
7. Centers for Disease Control and Prevention. Update: Influenza activity -United States, September 30-December 1, 2007. MMWR - Morb Mortal Wkly Rep 2007; 56:1287-1291.
8. Fedorko DP, Nelson NA, McAuliffe JM, Subbarao K. Performance of rapid tests for detection of avian influenza A virus types H5N1 and H9N2. J Clin Microbiol 2006; 44:1596-1597.
9. CDC-NIH. Interim CDC-NIH Recommendation for Raising the Biosafety Level for Laboratory Work Involving Noncontemporary Human Influenza Viruses. Excerpted from the Draft Biosafety in Microbiological and Biomedical Laboratories, 5th edn. 2006. Available from: http://www.cdc.gov/flu/ h2n2bsl3.htm (accessed 12 January 2006).
10. Bright RA, Medina MJ, Xu X et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: A cause for concern [see comment]. Lancet 2005; 366:1175-1181.
11. Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States [see comment]. JAMA 2006; 295:891-894.
12. Centers for Disease Control and Prevention. High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents - United States, 2005-06 influenza season. MMWR - Morb Mortal Wkly Rep 2006; 55:44-46.
13. WHO. WHO Recommended Surveillance Standards, 2nd edn. 2006. Available from: http://www.who.int/csr/resources/publications/surveillance/ WHO_CDS_CSR_ISR_99_2_EN/en/ (accessed 12 January 2006).
14. Schrag SJ, Shay DK, Gershman K et al. Multistate surveillance for laboratory-confirmed, influenza-associated hospitalizations in children: 2003-2004. Pediatr Infect Dis J 2006; 25:395-400.
15. Poehling KA, Edwards KM, Weinberg GA et al. The underrecognized burden of influenza in young children [see comment]. N Engl J Med 2006; 355:31-40.
16. Grijalva CG, Craig AS, Dupont WD et al. Estimating influenza hospitalizations among children. Emerg Infect Dis 2006; 12:103-109.
17. Thompson WW, Shay DK, Weintraub E et al. Mortality associated with influenza and respiratory syncytial virus in the United States [see comment]. JAMA 2003; 289:179-186.
18. Thompson WW, Comanor L, Shay DK. Epidemiology of seasonal influenza: Use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis 2006; 194(Suppl. 2):S82-S91.
19. Izurieta HS, Thompson WW, Kramarz P et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children [see comment]. N Engl J Med 2000; 342:232-239.
20. Bhat N, Wright JG, Broder KR et al. Influenza-associated deaths among children in the United States, 2003-2004 [see comment]. N Engl J Med 2005; 353:2559-2567.